Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Nov;35(11):3094-3101.
doi: 10.1038/s41433-020-01305-z. Epub 2021 Jan 19.

Early angiographic signs of retinopathy of prematurity requiring treatment

Collaborators, Affiliations
Observational Study

Early angiographic signs of retinopathy of prematurity requiring treatment

Domenico Lepore et al. Eye (Lond). 2021 Nov.

Abstract

Background/objectives: Fluorescein angiography (FA) has been a pivotal tool to study the pathophysiology of retinopathy of prematurity (ROP) in vivo. We examined the course of ROP using FA in order to assess the predictive value of angiographic features.

Subjects/methods: This is an observational retrospective cohort multi-center study of eyes screened for ROP with binocular indirect ophthalmoscope and with FA. All infants undergoing screening examination for ROP who had retinal vasculature limited to Zone I and posterior Zone II vascularization underwent FA between 31 and 34 weeks postmenstrual age. RetCam fundus imaging and video digital fluorescein angiography were performed in the neonatal intensive care units. Masked grading of the FA images was retrospectively conducted by two ROP expert ophthalmologists. Ten criteria that describe retinovascular and choroidal features on FA were used to assess their predictive value for development of treatment-requiring ROP.

Results: A total of 98 eyes of 56 patients were included for this study. FAs of eyes of premature infants show a wide range of features either at the junction between the vascular and avascular retina and posteriorly to that. Among the angiographic features evaluated, leakage, shunts and hyperfluorescent lesions at the junction between vascular and avascular zone were predictive of the development of treatment-requiring ROP (p < 0.05), but findings in the posterior vascularized retina were not.

Conclusions: FA can add to our understanding of the evolution of vascular abnormalities in the course of ROP and can help predict which eyes will go on to treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no conflict of interest.

Figures

Fig. 1
Fig. 1. FA abnormalities within the vascularized retina.
a Absence of foveal avascular zone, b Presence of foveal avascular zone, c Linear pattern of the choroidal vascular circulation, d Lobular pattern of the choroidal vascular circulation, e Hypofluorescent area surrounded by hyperfluorescence, f Hypofluorescent area without surrounding hyperfluorescence.
Fig. 2
Fig. 2. FA abnormalities at the junction between vascular and avascular retina.
a Finger-like vascular branching pattern, b Naked arteriovenous shunt, c Capillary tangles, d Hyperfluorescent lesions, e Perivascular dye leakage, f capillary obliteration.

References

    1. International Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol. 1984;102:1130–4. doi: 10.1001/archopht.1984.01040030908011. - DOI - PubMed
    1. Aaberg T, Ben-Sira I, Charles S, Clarkson J, Cohen BZ, Flynn J, et al. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1987;105:906–12. doi: 10.1001/archopht.1987.01060070042025. - DOI - PubMed
    1. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991–9. doi: 10.1001/archopht.123.7.991. - DOI - PubMed
    1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol. 1988;106:471–9. doi: 10.1001/archopht.1988.01060130517027. - DOI - PubMed
    1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol. 2001;119:1110–8. doi: 10.1001/archopht.119.8.1110. - DOI - PubMed

Publication types

MeSH terms